Business · 30/07/2020
FDA Releases Draft Guidance on Labeling for Human Prescription Drugs and Biological Products
The FDA is releasing a draft guidance to help pharmaceutical companies comply with labeling requirements for human prescription drugs and biological products, particularly those related to pregnancy, lactation, and reproductive potential.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →